BioNTech SE (BNTX) Inventory Average (2019 - 2025)

BioNTech SE has disclosed Inventory Average across 6 years of filings, most recently posting $196.4 million for Q4 2025.

• Inventory Average for Q4 2025 came in at $196.4 million, down 38.21% year-over-year; the trailing twelve-month figure through Dec 2025 was $196.4 million (down 38.21% YoY), and the FY2025 annual result was $213.9 million, down 37.78% from the prior year.
• Inventory Average came in at $196.4 million for Q4 2025 at BioNTech SE, down from $262.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $545.2 million in Q1 2022 to a low of $126.8 million in Q1 2021.
• The 5-year median for Inventory Average is $370.7 million (2024), against an average of $357.8 million.
• Across the five-year window, Inventory Average surged 329.91% in 2022 and tumbled 38.21% in 2025, its largest moves.
• BioNTech SE's Inventory Average stood at $126.8 million in 2021, then surged by 194.04% to $372.9 million in 2022, then advanced by 12.29% to $418.7 million in 2023, then retreated by 24.1% to $317.8 million in 2024, then slumped by 38.21% to $196.4 million in 2025.
• The last three Inventory Average figures came in at $196.4 million (Q4 2025), $262.5 million (Q3 2025), and $264.4 million (Q2 2025), per Business Quant data.